In this experiment, CM from breast cancer cell lines suppressed PPARγ and its target genes FABP4 and CD36 in both ECs (Fig. 5E) and pericytes (Fig. 5F) compared to CM from HMECs. The gene discussed is CD36; the disease is breast cancer.